The majority (79%) of FH cases are attributed to mutations in the LDL receptor (LDLR) gene, leading to abnormalities in LDLR synthesis, assembly, transport, recycling, or impaired LDL endocytosis. The gene discussed is LDLR; the disease is familial hyperaldosteronism.